1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE

1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE Basic information
Product Name:1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE
Synonyms:1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE;DR 2313;7,8-Dihydro-2-methyl-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one;3,5,7,8-Tetrahydro-2-methyl-4H-thiopyrano[4,3-d]pyrimidin-4-one;4H-Thiopyrano[4,3-d]pyriMidin-4-one,3,5,7,8-tetrahydro-2;4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE,3,5,7,8-TETRAHYDRO-2-METHYL-;SC-202756;2-Methyl-1-sulfanyl-1H,4H,5H,7H,8H-pyrano[4,3-d]pyriMidin-4-one
CAS:284028-90-6
MF:C8H10N2OS
MW:182.24
EINECS:200-589-5
Product Categories:
Mol File:284028-90-6.mol
1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE Structure
1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE Chemical Properties
Boiling point 349.3±52.0 °C(Predicted)
density 1.46±0.1 g/cm3(Predicted)
storage temp. Sealed in dry,2-8°C
solubility H2O: >2mg/mL (warmed)
form powder
pka1.54±0.20(Predicted)
color white to beige
Safety Information
WGK Germany 3
MSDS Information
1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE Usage And Synthesis
Biological ActivityPotent, competitive inhibitor of poly(ADP-ribose) polymerase (PARP) (IC 50 values are 0.20 and 0.24 μ M for PARP-1 and PARP-2 respectively). Neuroprotective; reduces neuronal cell death in models of cerebral ischemia in vivo and in vitro . Brain penetrant.
1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE Preparation Products And Raw materials
NU1025 3-Aminobenzamide 4-AMINO-1,8-NAPHTHALIMIDE TIQ-A 3-(4-CHLORO-PHENYL)-QUINOXALINE-5-CARBOXYLIC ACID AMIDE ABT-888 DPQ Rucaparib 4-Hydroxyquinazoline 5-Benzoyloxy-1(2H)-isoquinolinone 1(2H)-Isoquinolinone, 5-aMino-, Monohydrochloride 1,5-ISOQUINOLINEDIOL Minocycline hydrochloride Benzamide PF-01367338 PJ-34 1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.